Back to VA VANGUARD CAPITAL MANAGEMENT LLC
CLDX2 quarters
Position history for VAVANGUARD CAPITAL MANAGEMENT LLC's holdings in Celldex Therapeutics, Inc.
VANGUARD CAPITAL MANAGEMENT LLC holds 3.5M shares of CLDX (Celldex Therapeutics, Inc.), worth $128.9M as of 2026-Q2. The position was increased (+17.0% shares). CLDX represents 0.0% of VANGUARD CAPITAL MANAGEMENT LLC's portfolio.
Current Value
$128.9M
Current Shares
3.5M
Total Value Change
+$35M
Total Shares Change
+503,936
Quarter-by-Quarter History
Other major holders of CLDX: BNP PARIBAS FINANCIAL MARKETS, WELLINGTON MANAGEMENT GROUP LLP